Relationship between cocaine-induced hepatotoxic neurobehavioral and biochemical changes in mice: The antidotal effects of buprenorphine

Life Sciences

Volumn 67, Issue 1, 2000, Pages 45-52

  Hayase, Tamaki ^a   Yamamoto, Yoshiko ^a   Yamamoto, Keiichi ^a   Abiru, Hitoshi ^a   Nishitani, Yoko ^a   Fukui, Yuko ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ALT; ATP; Biochemical changes; Buprenorphine; Cocaine; Hepatotoxicity; Neurobehavioral symptoms

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; ANTIDOTE; BUPRENORPHINE; COCAINE; THIOACETAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; ENZYME ACTIVITY; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PREMEDICATION;

ADENOSINE TRIPHOSPHATE; ALANINE TRANSAMINASE; ANIMALS; ANTIDOTES; BEHAVIOR, ANIMAL; BRAIN; BUPRENORPHINE; COCAINE; DISEASE MODELS, ANIMAL; HEPATIC ENCEPHALOPATHY; LIVER; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; NARCOTIC ANTAGONISTS; NARCOTICS;

ANIMALIA; ERYTHROXYLUM;

EID: 0034717154     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00599-3     Document Type: Article

References (32)

1. J.K. Staley, W.L. Hearn, A.J. Ruttenber, C.V. Wetli and D.C. Mash, J. Pharmacol. Exp. Ther. 271 1678-1685 (1994).
2. M.D. Schechter and S.M. Meehan, Pharmacol. Biochem. Behav. 51 521-523 (1995).
3. L.E. Perino, G.H. Warren and J.S. Levine, Gastroenterology 93 176-180 (1987).
4. I.R. Wanless, S. Dore, N. Gopinath, J. Tan, R. Cameron, E.J. Heathcote, L.M. Blendis and G. Levy, Gastroenterology 98 497-501 (1990).
5. E.A. Jones and K. Weissenborn, J. Neurol. Neurosurg. Psychiatry 63 279-293 (1997).
6. R.C. James, M.A. Schiefer, S.M. Roberts and R.D. Harbison, J. Pharmacol. Exp. Ther. 242 726-732 (1987).
7. S.M. Roberts, R.P. Demott and R.C. James, Drug Metab. Rev. 29 329-353 (1997).
8. M.C. Ritz and F.R. George, J. Pharmacol. Exp. Ther. 264 1333-1343 (1993).
9. H.U. Bryant, J.A. Story and G.K. Yim, Psychosom. Med. 50 576-585 (1988).
10. C. Yurdaydin, Y. Li, J.H. Ha, A. Jones, R. Rothman and A.S. Basile, J. Pharmacol. Exp. Ther. 273 185-192 (1995).
11. C. Yurdaydin, D. Karavelioglu, O. Onaran, T. Celik, M.H. Yasa and O. Uzunalimoglu, J. Hepatol. 29 796-801 (1998).
12. S.M. Meehan and M.D. Schechter, Gen. Pharmacol. 26 99-106 (1995).
13. J.M. Witkin, R.E. Johnson, J.H. Jaffe, S.R. Goldberg, N.A. Grayson, K.C. Rice and J.L. Katz, Drug Alc. Depend. 27 177-184 (1991).
14. V.K. Shukla, L.R. Goldfrank, H. Turndorf and M. Bansinath, Life Sci. 49 1887-1893 (1991).
15. N.K. Mello, J.H. Mendelson, S.E. Lukas, D.R. Gastfriend, S.K. Teoh and B.L. Holman, Harv. Rev. Psychiatry 1 168-183 (1993).
16. C.S. Boyer and D.R. Petersen, J. Pharmacol. Exp. Ther. 260 939-946 (1992).
17. National Research Council, Guide for Care and Use of Laboratory Animals (NIH Publication No. 85-23), National Institutes of Health, Bethesda (1985).
18. M.W. Kloss, G.M. Rosen and E.J. Rauckman, Toxicol. Appl. Pharmacol. 65 75-83 (1982).
19. Kyoto Blood Research Laboratory, Blood Research Manual, Blood Research Laboratory Co. Ltd., Kyoto (1996). (in Japanese)
20. Sigma Diagnostics, Adenosine-5′-triphosphate Reagents Instruction Manual, Sigma Chemical Co., St. Louis (1995).
21. P. Steindl, A. Püspök, W. Druml and P. Ferenci, Hepatology 14 963-968 (1991).
22. Y. Itzhak, A. Roig-Cantisano, R.S. Dombro and M.D. Norenberg, Brain Res. 705 345-348 (1995).
23. Shakai Johou Service, Manual of Medical Statistics, Shakai Johou Service Co. Ltd., Tokyo (1993). (in Japanese)
24. T. Hayase, Y. Yamamoto, K. Yamamoto, H. Abiru and Y. Fukui, Jpn. J. Alcohol & Drug Dependence 32 308-309 (1997). (in Japanese)
25. C.S. Boyer and D.R. Petersen, Hepatology 14 1209-1216 (1991).
26. B.G. Devi and A.W. Chan, J. Cardiovasc. Pharmacol. 33 1-6 (1999).
27. J.E. Koch, H. Ji, M.D. Osbakken and M.I. Friedman, Am. J. Physiol. 274 R610-R617 (1998).
28. T. Hayase, Y. Yamamoto and K. Yamamoto, J. Toxicol. Sci. 21 143-156 (1996).
29. C.G. Pick, Y. Peter, S. Schreiber and R. Weizman, Brain Res. 744 41-46 (1997).
30. K.D. Nantwi, S. Hicks, D. Bradley Jr and E.P. Schoener, Gen. Pharmacol. 31 425-429 (1998).
31. J.E. Pedersen, B. Chraemmer-Jorgensen, J.F. Schnidt and A. Risbo, Br. J. Anaesth. 57 1045-1046 (1985).
32. R.W. Derlet, C.C. Tseng, R.S. Tharratt and T.E. Albertson, Am. J. Med. Sci. 303 165-169 (1992).